The MPN Interferon Initiative

Dr. Joseph Scandura selected as one of four investigators for a new, multi-institution project launching in 2018: The MPN Interferon Initiative. This research project aims to evaluate how targeting the interferon pathway can be used to treat MPN patients and why this is effectively in only a subset of patients. The MPN Interferon Initiative is a partnership between MPN Research Foundation, Northwestern University and Cancer Research & Treatment Fund (CR&T).

The initial team of investigators includes:
  • Leonidas Platanias, MD, PhD: Lurie Cancer Center
  • Ann Mullally, MD: Division of Hematology, Brigham and Woman's Hospital
  • Jean-Luc Villeval, PhD: INSERM/Institut Gustave Roussy, Paris
  • Joseph Scandura, MD, PhD: Weill Cornell School of Medicine
The MPN Research Foundation was founded in 2000 by a group of patients and funds innovative research with the goal of expanding knowledge regarding myeloproliferative neoplasms and ultimately finding cures for this group of diseases.

Richard T. Silver MD Myeloproliferative Neoplasms Center 525 East 70th St., Starr Pavillion, 3rd Floor New York, NY 10021